• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,273.45 1,205.00
( 1.63%)
Global Indices
Nasdaq
46,146.75 -82.73
(-0.18%)
Dow Jones
6,578.03 -23.97
(-0.36%)
Hang Seng
53,715.15 1,462.87
(2.80%)
Nikkei 225
9,942.10 47.95
(0.48%)
Forex
USD-INR
93.53 0.04
(0.04%)
EUR-INR
108.22 0.07
(0.07%)
GBP-INR
125.01 0.33
(0.27%)
JPY-INR
0.59 0.00
(0.23%)

EQUITY - MARKET SCREENER

Vaishali Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
535000
INE972X01022
5.1647115
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VAISHALI
0
75.02
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

Hyundai Motor clocks total sales of 66,134 units in Feb'26
Mar 02,2026

The company’s total sales for February 2025 were 58,727 units.

While domestic sales rose by 9.8% YoY to 52,407 units, exports increased by 24.8% to 13,727 units in February 2026.

Hyundai Motor India manufactures and sells passenger cars, along with vehicle parts and accessories.

The company had reported a 6.34% rise in consolidated net profit to Rs 1,234.40 crore on a 7.96% increase in total revenue from operations to Rs 17,973.49 crore in Q3 FY26 as compared with Q3 FY25.

The scrip fell 1.77% to currently trade at Rs 2125.35 on the BSE.